LaurenceM.CorashMD

Hematology • San Francisco, CA

Physician

Join to view full profile

Dr. Corash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Corash's full profile

Already have an account?

Office
505 Parnassus Ave
San Francisco, CA 94143
Phone+1 415-353-1672

Fax+1 415-353-1804

Education & Training

NYU Grossman School of MedicineResidency, Internal Medicine, 1969 - 1971
New York University School of MedicineClass of 1969

Certifications & Licensure

CA State Medical License 1982 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Pathology Hematology

Publications & Presentations

PubMed

In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assay.
Anne North, Katherine Ling, Guillaume Ricaud, Leon F Stankowski Jr, Jennifer A Daly
Transfusion. 2024-06-01
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components.
Allison P Wheeler, Edward L Snyder, Majed Refaai, Claudia S Cohn, Jessica Poisson
Blood Advances. 2024-05-14
3 citations
Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-pro...
Edward L Snyder, Michael E Sekela, Ian J Welsby, Yoshiya Toyoda, Mohamed Alsammak
Trials. 2023-12-11

Abstracts/Posters

Impact of Amotosalen/UVA Pathogen Inactivated Platelet Components on Outcomes after Allogeneic Hematopoetic Stem Cell Transplantation: A Single Center Analysis
Laurence Corash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

A Sequential Cohort Study of Pathogen Reduced Platelet Component Transfusion without Use of Leukocyte Reduction for Hematopoietic Stem Cell Transplant (HSCT): Impact o...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Cerus Corporation Celebrates World Blood Donor Day 2021June 14th, 2021
Cerus Corporation Announces Presentation of Study Results with INTERCEPT-Treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual MeetingDecember 4th, 2020
Cerus Corporation : Announces a Five-Year Tender Award by the Hong Kong Red Cross Blood Transfusion Service for INTERCEPT Blood SystemsJuly 30th, 2020
Join now to see all